P3 Health Partners Inc. Common Stock earnings per share and revenue
On Nov 13, 2025, PIII reported earnings of -9.67 USD per share (EPS) for Q3 25, missing the estimate of -6.15 USD, resulting in a -57.05% surprise. Revenue reached 345.25 million, compared to an expected 353.57 million, with a -2.35% difference. The market reacted with a -2.29% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -9.65 USD, with revenue projected to reach 364.80 million USD, implying an decrease of -0.21% EPS, and increase of 5.66% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Doximity, Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$0.45
Actual
$0.46
Surprise
+1.21%
Omnicell Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.50
Actual
$0.40
Surprise
-20.98%
Azenta, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$0.14
Actual
$0.09
Surprise
-35.94%
FAQ
What were P3 Health Partners Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, P3 Health Partners Inc. Common Stock reported EPS of -$9.67, missing estimates by -57.05%, and revenue of $345.25M, -2.35% below expectations.
How did the market react to P3 Health Partners Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.29%, changed from $7.00 before the earnings release to $6.84 the day after.
When is P3 Health Partners Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 25, 2026.
What are the forecasts for P3 Health Partners Inc. Common Stock's next earnings report?
Based on 5
analysts, P3 Health Partners Inc. Common Stock is expected to report EPS of -$9.65 and revenue of $364.80M for Q4 2025.